Markets.com Logo

BIOAF

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.0001$
  • Previous Close
    0.0001$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0001$ - 0.0004$
  • Dividend Per Share
    --
  • Market cap
    289 K$
  • EPS
    0
  • Beta
    34.975
  • Volume
    --

About

BIOAF.US represents shares of Bio Affinity Technologies, Inc., a company focused on developing and commercializing proprietary platform technology for the selective removal of toxins from biological fluids. Their primary focus has been on developing devices and therapies for the treatment of sepsis and other inflammatory conditions. The company's technology centers around a proprietary biosorbent material that aims to bind and remove specific toxins from the bloodstream, potentially mitigating the effects of these toxins on the body and improving patient outcomes. Bio Affinity Technologies operates primarily within the medical device and biotechnology sectors.

Who Controls the Strait of Hormuz: The Decisive Battle in the US-Iran Conflict

Ava Grace|--

Meta's Latest Layoffs: Signal of Redundancy or AI Investment Returns?

Noah Lee|--

Senior US Official Resigns, Citing Israeli Pressure and False Threats as Motivation for Iran War

Liam James|--

US Economic Outlook Deteriorates as Hormuz Strait Stays Closed

Noah Lee|--

Navigating Geopolitical Shocks: An Investor's Framework for the Iran Conflict

Ava Grace|--

Heraeus Analysis: War, Oil Shocks, and Recession's Impact on Precious Metals

Ava Grace|--

Fed Policy at Crossroads: Geopolitical Shocks and Inflationary Pressures

Sophia Claire|--

Factors

Please do not include any intro or closing. Company Performance: Revenue growth, profitability, and pipeline progress in developing biosimilar and generic drugs influence investor confidence.

Regulatory Approvals: Positive decisions from regulatory bodies like the FDA for new products significantly impact stock price.

Market Competition: The presence of competitors and pricing pressures in the biosimilar and generic drug market affect revenue and market share.

Patent Litigation: Legal battles over patents for existing drugs can create uncertainty and affect future profitability.

Economic Conditions: Broader economic factors like inflation and interest rates can influence investment decisions and overall market sentiment towards pharmaceutical stocks.

Industry Trends: Shifts in healthcare policies, such as reimbursement rates for biosimilars, can impact the company's financial outlook.

Investor Sentiment: General investor perception and market trends can lead to fluctuations in stock price, sometimes unrelated to the company's fundamentals.

Management Team: The experience and strategic decisions of the management team impact investor confidence and the company's long-term prospects.

People Also Watch

Latest news

Geopolitical Shocks Reshape Fed's Inflation Fight, Complicating Rate Cut Outlook

Emma Rose|--

Belgian PM's Call for Russia Energy Normalization Sparks EU Debate

Emma Rose|--

Forex Carry Trades Thrive on Oil Surge Amid Geopolitical Tensions

Noah Lee|--

Latest Education Articles

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Commodity Market Terms: What Are Basic Commdity Market Terms for Beginners in UAE?

Ghko B|--
How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

How to trade top 3 cryptos in UAE: Bitcoin (BTC/USD), Ethereum (ETH/USD), Ripple (XRP/USD)?

Ghko B|--
Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Crypto trading for beginners: How to trade Bitcoin (BTC/USD) in UAE & Dubai?

Ghko B|--